drugset / Trial / NCT04085575

Efficacy of Intra-auricular Tranexamic Acid in Total Knee Arthroplasty

NCT04085575

Phase 4 Completed 100 enrolled Centre Hospitalier de Montauban
RandomizedParallel-groupDouble-blindTreatment

Summary

Tranexamic acid an antifibrinolytic that develops its anti-haemorrhagic action by inhibiting fibrinolytic activities of plasmin and many studies confirms its effectiveness in decreasing blood loss. The aim of this study was to observe postoperative bleeding with combined intravenous and per - os administration with two intra - articular doses (1 g and 2 g) of tranexamic acid in adult patients undergoing unilateral total knee replacement.

Timeline

Start
2019-01-01
Primary completion
2019-12-09
Completion
2020-01-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 10 mg/kg Other
Comparator Tranexamic Acid Small molecule 1 g Other
Comparator Tranexamic Acid Small molecule 2 g Other

Indications

No indication recorded.